Bionano Genomics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 36.12 million compared to USD 27.8 million a year ago. Net loss was USD 232.49 million compared to USD 132.6 million a year ago.

Basic loss per share from continuing operations was USD 6.81 compared to USD 4.58 a year ago. Diluted loss per share from continuing operations was USD 6.81 compared to USD 4.58 a year ago.